Stem Cell Banking Market Size 2021
Stem cell banking offers people, an opportunity to have their cells cryogenically frozen at a time when they are perfectly healthy. The cells can be stored and kept safely for decades. Years later, people can use those cells at the time of requirement which can be during old age. Today as the medical science progresses, processes regarding stem cell collection and safe-keeping are safe, non-invasive and risk free. In the coming years, stem cell therapies can benefit many people. Hence, the market stem cell banking is growing.
Access Full Report Details and Order this Premium Report @ https://www.absolutemarketsinsights.com/reports/Stem-Cell-Banking-Market-2021---2029-860
Major Key Players:
Some of the major players operating in the global Stem Cell Banking Market Size are CBR Systems, Inc., Cell Care, CHA Biotech, CordBank New Zealand, Cordlife, Cryo-Cell, CryoHoldco, Cryoviva India, CSG-BIO, Global Cord Blood Corporation., LifeCell International Pvt. Ltd., ReeLabs Pvt. Ltd., Regrow Biosciences Pvt Ltd., Smart Cells International Ltd., Stem Med Pte Ltd, StemCyte, ViaCord and Vita 34 Inc. amongst others.
Key findings of the report:
The global Stem Cell Banking Market Size is anticipated to reach US$ 15089.64 Mn by 2029 growing at a CAGR of 10% during the forecast period (2021-2029).
Umbilical cord accounted for the largest source in the global Stem Cell Banking Market Size in 2020. Cord blood stem cells can be used in therapies and transplants to treat over 85 ailments that include anaemias (different types), bone marrow cancer, leukaemias (different types), and lymphomas. More than 5,000 clinical trials are using stem cell therapies today.
In the context of medical condition, higher market share in the global Stem Cell Banking Market Size was held by cancer (leukaemias, lymphomas, etc.) in 2020. Stem cells can be used for the treatment of different types of cancer such as acute biphenotypic leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, acute undifferentiated leukemia, chronic myelogenous leukemia, chronic lymphocytic leukemia, juvenile myelomonocytic leukemia, and juvenile chronic myelogenous leukemia. In regenerative medicine, the use of stem cells has been in vogue for a long time. It is very common in the field of dermatology.
Considering the applications segment, the disease treatment & tissue regeneration segment occupied the largest market share in 2020. Stem cells that are used in disease treatment & tissue regeneration have the potential to treat various medical conditions including different types of blood cancers. They can also treat various disorders such as genetic disorders, immunity-related disorders, and metabolic disorders. The US FDA has approved the use of cord blood stem cells for the treatment of 80 diseases. Through replacement and repair approaches, stem cells are used in many medicine. Regarding tissue regeneration, stem cells can be used for repairing and restoring the damaged tissues or organs. This treatment is helpful in case of severe injuries and chronic diseases. Such stem cells can generate healthy cells that can replace diseased cells.
In 2020, North America dominated the global Stem Cell Banking Market Size. Advanced medical research being carried out in many biology-based scientific institutions in USA and Canada is aiding the region’s growth in the global market. Developed medical sector, presence of key market players, technological advancement aiding medical research, and higher investment in medical research are some other major factors that contributed to the market growth in this region.
Market Segmentation
By Service Type
Storage
Testing and Processing
Collection
By Source
Umbilical Cord
Placenta
Amniotic Fluid
Bone Marrow
Others
By Medical Condition
Cancer (Leukaemias, Lymphomas, Etc.)
Non Malignant Blood Disorders (Anaemias, Hereditary Bone Marrow Failure Syndromes, Etc.)
Immune Disorder (Severe Combined Immune Deficiency (SCID), Inherited Immune System Disorders, etc.)
Metabolic Disorders (Leukodystrophy Disorders, Mucopolysaccharidosis (MPS) Storage Diseases, Etc.)
Others
By Application
Disease Treatment & Tissue Regeneration
Clinical Research
Personalized Banking Applications
By Region
North America
U.S.
Canada
Mexico
Rest of North America
Europe
France
The UK
Spain
Germany
Italy
Nordic Countries
Denmark
Finland
Iceland
Sweden
Norway
Benelux Union
Belgium
The Netherlands
Luxembourg
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Southeast Asia
Indonesia
Thailand
Malaysia
Singapore
Rest of Southeast Asia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
.…
Contact us:
Shreyas Tanna
Phone: +91-740-024-2424
Absolute Markets Insights
